The Long Road: Treatment, Recovery, and Lasting Health Effects of COVID-19
Two attendance options:
"#CovidVaccine! I got it for my family, my team of coworkers, but most importantly for my patients. The ones who I’ve talked to while sedated, held the iPad for so loved ones could say goodbye, and held their hand as they have slipped away from this world. #COVID #MaskUp" - Nikki LaFratte, BSN, RN, CCRN, Panel Member
After a steady decline since January 2021, COVID-19 cases and hospitalizations in Iowa have risen dramatically since July 2021. Resources and guidelines related to COVID-19 are constantly changing and new scientific evidence is emerging on a daily basis. In late July 2021, the Centers for Disease Control and Prevention released updated guidance related to the newly discovered Delta variant, which has added another level of uncertainty for healthcare providers and patients alike. Additionally, in August 2021, the U.S. Food and Drug Administration amended the emergency use authorizations for both the Pfizer-BioNTech and Moderna COVID-19 vaccines to allow for the administration of a third dose for certain individuals. This constant flow of information can make it difficult for healthcare providers to keep up with the current scientific environment.
Discovery of new evidence also contributes to changes in treatment recommendations in hopes of improving patient outcomes. Although most individuals that contract COVID-19 recover easily and have minimal impact to their overall health, some people experience a wide range of lasting conditions that may extend well beyond four weeks from their initial diagnosis. These lasting health effects vary in symptomology and duration, and can be easily missed or mistaken for another condition. It is essential that healthcare providers stay abreast of the current scientific evidence and acknowledge the role of treatment and recovery in the long-term wellbeing of their patients.
DMU faculty, staff, students, residents, and the medical community.
- Empathize with the patient journey, including fears, virtual family interactions, and recovering from COVID-19 infection.
- List three factors that are contributing to the current rise in COVID-19 cases and hospitalizations in Iowa.
- Compare and contrast symptomology and treatment recommendations related to the Delta variant of the virus.
- List the primary differences between a patient that is diagnosed with COVID-19 versus other respiratory infections.
- Describe the patient populations that may benefit from a third dose of the COVID-19 vaccine.
IMPORTANT! Due to the COVID-19 pandemic, DMU is closed to external visitors. Only individuals with an active DMU badge may attend on-site.
Aneesa Afroze, MD, MPH, FACP, AAHIVS, CTH
Infectious Disease Consultant, Antimicrobial Stewardship Program Director, and Medical Staff President, MercyOne Des Moines Pulmonary & Infectious Disease Care
Nikki LaFratte, BSN, RN, CCRN
Critical Care Nurse, MercyOne Des Moines and Assistant Professor, Mercy College of Health Sciences
"#CovidVaccine! I got it for my family, my team of coworkers, but most importantly for my patients. The ones who I’ve talked to while sedated, held the iPad for so loved ones could say goodbye, and held their hand as they have slipped away from this world. #COVID #MaskUp" - Nikki LaFratte
- MD: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Iowa Medical Society (IMS). Des Moines University (DMU) is accredited by the IMS to provide continuing medical education for physicians. DMU designates this live activity for 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- DO: Des Moines University (DMU) is accredited by the American Osteopathic Association (AOA) to provide osteopathic continuing medical education for physicians. DMU designates this program for a maximum of 1.0 AOA Category 1-B credits and will report CME and specialty credits commensurate with the extent of the physician’s participation in this activity.
- Nurse: Des Moines University is Iowa Board of Nursing approved provider #112. This live activity has been reviewed and approved for 1.0 continuing education contact hour(s). No partial credit awarded.
- Other healthcare providers: This live activity is designated for 1.0 AMA PRA Category 1 Credit(s)™.
No commercial interest provided financial support for this continuing education activity.
The speaker(s) will disclose if any pharmaceuticals or medical procedures and devices discussed are investigational or unapproved for use by the U.S. Food and Drug Administration (FDA). Determination of educational content and the selection of speakers is the responsibility of the activity director.
Relevant to the content of this educational activity, the following individual(s) have no conflict(s) with ineligible companies to disclose.
- Aneesa Afroze, MD, MPH, FACP, AAHIVS, CTH - Speaker
- Phill Butler - Speaker
- Nikki LaFratte, BSN, RN, CCRN - Speaker
The information provided at this activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition. The content of each presentation does not necessarily reflect the views of Des Moines University.
- 1.00 AMA PRA Category 1 Credits™
- 1.00 AOA Category 1B
- 1.00 CE Contact Hour(s)
- 1.00 IBON
Two attendance options:
- Des Moines University students, faculty, and staff - No registration is necessary to attend on-site or register through Zoom to attend on-line.
- All other interested individuals - Due to the COVID-19 pandemic, DMU is closed to external visitors. Only individuals with an active DMU badge may attend on-site. Register through Zoom.